With Eli Lilly's diabetes and obesity products Mounjaro and Zepbound booming in popularity, the drugmaker finds itself in a ...
Eli Lilly announces $15 billion share buyback plan and 15% dividend boost amidst mixed technical signals. Investors are ...
The company also raised its quarterly dividend 15% amid rapid growth fueled in part by the blockbuster weight-loss drug ...
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...
Eli Lilly and Company LLY announced that its board of directors approved a new $15 billion share buyback plan. The earlier $5 ...
One particular healthcare stock has shown its ability to soar on good news -- and it's had plenty of it. This year the ...
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), AbbVie ...
Olson, a 19-year veteran of the mechanical contracting leader, takes over for Gus Simonds, now Executive Chair of the Board ...
A blood test being developed by Roche and Eli Lilly that could help diagnose patients with Alzheimer’s disease more quickly has been awarded breakthrough status by the FDA, which could help it ...
The chemistry, pharmacokinetics, pharmacodynamics, clinical efficacy, dosage and administration, adverse effects, and therapeutic role of tinzaparin are reviewed. Tinzaparin is a low-molecular ...
A New South Wales man has avoided jail time after becoming the first person charged under the state's new coercive control laws.
Netflix has revealed some more first looks and a new English-language name for its new Italian action drama series, Public Disorder. It was previously developed under the name A.C.A.B. La Series, ...